List of Excipients in API disopyramide phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing disopyramide phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | FD&C RED NO. 3 | |
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | FD&C YELLOW NO. 6 | |
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | GELATIN | |
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | LACTOSE | |
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | STARCH, CORN | |
| Pfizer Laboratories Div Pfizer Inc | NORPACE | disopyramide phosphate | 0025-2752 | TALC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing disopyramide phosphate
Detailed excipient profiles for disopyramide phosphate
Excipient focus: ALUMINUM OXIDE
disopyramide phosphate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | disopyramide phosphate | 42291-234 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
disopyramide phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | disopyramide phosphate | 51407-131 |
| Mayne Pharma Commercial LLC | disopyramide phosphate | 51862-095 |
| Golden State Medical Supply Inc | disopyramide phosphate | 60429-984 |
| Dr Reddy's Labratories Inc | disopyramide phosphate | 75907-027 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C RED NO. 28
disopyramide phosphate drug variants containing D&C RED NO. 28
disopyramide phosphate drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
disopyramide phosphate drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| AvKARE | disopyramide phosphate | 42291-234 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
disopyramide phosphate drug variants containing D&C YELLOW NO. 10
disopyramide phosphate drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
disopyramide phosphate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: ETHYLCELLULOSES
disopyramide phosphate drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
disopyramide phosphate drug variants containing FD&C BLUE NO. 1
disopyramide phosphate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
disopyramide phosphate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
disopyramide phosphate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | disopyramide phosphate | 42291-234 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
disopyramide phosphate drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 3
disopyramide phosphate drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
disopyramide phosphate drug variants containing FD&C RED NO. 40
disopyramide phosphate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
disopyramide phosphate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
disopyramide phosphate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
disopyramide phosphate drug variants containing GELATIN
disopyramide phosphate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
disopyramide phosphate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
disopyramide phosphate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
disopyramide phosphate drug variants containing MAGNESIUM STEARATE
disopyramide phosphate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
disopyramide phosphate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | disopyramide phosphate | 51407-131 |
| Mayne Pharma Commercial LLC | disopyramide phosphate | 51862-095 |
| Golden State Medical Supply Inc | disopyramide phosphate | 60429-984 |
| Dr Reddy's Labratories Inc | disopyramide phosphate | 75907-027 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing METHYLPARABEN
Excipient focus: PROPYLENE GLYCOL
disopyramide phosphate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| AvKARE | disopyramide phosphate | 42291-234 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
disopyramide phosphate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | disopyramide phosphate | 51407-131 |
| Mayne Pharma Commercial LLC | disopyramide phosphate | 51862-095 |
| Golden State Medical Supply Inc | disopyramide phosphate | 60429-984 |
| Dr Reddy's Labratories Inc | disopyramide phosphate | 75907-027 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing PROPYLPARABEN
Excipient focus: SHELLAC
disopyramide phosphate drug variants containing SHELLAC
disopyramide phosphate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
disopyramide phosphate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | disopyramide phosphate | 42291-234 |
| Golden State Medical Supply Inc | disopyramide phosphate | 60429-984 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
disopyramide phosphate drug variants containing SODIUM LAURYL SULFATE
disopyramide phosphate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
disopyramide phosphate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | disopyramide phosphate | 0093-3127 |
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITAN MONOLAURATE
disopyramide phosphate drug variants containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | disopyramide phosphate | 68151-0528 |
| Carilion Materials Management | disopyramide phosphate | 68151-3858 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing SORBITAN MONOLAURATE
Excipient focus: STARCH, CORN
disopyramide phosphate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
disopyramide phosphate drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing SUCROSE
Excipient focus: TALC
disopyramide phosphate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | disopyramide phosphate | 0025-2752 |
| Greenstone LLC | disopyramide phosphate | 59762-0386 |
| Carilion Materials Management | disopyramide phosphate | 68151-0526 |
| Carilion Materials Management | disopyramide phosphate | 68151-0527 |
| >Company | >Ingredient | >NDC |
disopyramide phosphate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
disopyramide phosphate drug variants containing TITANIUM DIOXIDE
disopyramide phosphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links